Avancerad sökning
Visar resultat 1 - 5 av 38 avhandlingar som matchar ovanstående sökkriterier.
1. Asymmetric Information and The Production of Health
Sammanfattning : The common theme of this thesis is the analysis of asymmetric information when applied to the market for health care production. The thesis consists of six more or less independent papers and an introduction to the thesis were purpose and methodology are stated (part one). Part two is an investigation into the pricing of pharmaceuticals in Sweden. LÄS MER
2. Swedish Pharmaceutical Benefit Reforms ?Analyses of implementation, pharmaceutical sales patterns and expenditures
Sammanfattning : Background: Over the last few decades, the sales of prescription drugs have increased dramatically in many western countries; however, this increase requires individuals and society to bear larger economic consequences. To improve cost control for pharmaceuticals, several reforms attempt to reconcile the economic responsibility of the patients, prescribers and third party payers. LÄS MER
3. Regress : Begreppet regressrätt och solidarregress
Sammanfattning : The right of recourse is a classic topic within law of obligations that spans traditional divisions into contractual and non-contractual law. Even so, there is a lack of consensus on what the right of recourse really entails. LÄS MER
4. Marketisation of Swedish Primary Care : Patient Choice, Provider Competition and Payment Incentives
Sammanfattning : In the last decades, market elements—such as patient choice, provider competition and payment incentives—have been introduced in Swedish primary care, the Patient Choice reform in 2010 being pivotal for the marketisation of the sector. The political intentions with the reform were to empower patients and increase provider diversity, thereby stimulating competition and improving quality and access. LÄS MER
5. Lipid‐modifying and glucose-lowering therapies in clinical practice : The impact of guidelines and changing reimbursement schemes
Sammanfattning : cardiovascular disease, which is still a major cause of death that creates large burdens to society in terms of costs and morbidity. Dyslipidemia and type 2 diabetes mellitus are the main risk factors for cardiovascular disease, and national and international guidelines recommend lipid-modifying and glucose-lowering treatments for prevention. LÄS MER
